You can buy or sell Immutep and other stocks, options, ETFs, and crypto commission-free!
Immutep Limited American Depositary Shares, also called Immutep, is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. Read More The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Sydney, New South Wales (NSW)
52 Week High
52 Week Low
Research And Development